SEATTLE, March 30, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global duck medicine and vaccines market is estimated to be valued at US$ 1,777.0 million in 2021 and is expected to exhibit a CAGR of 7.7% during the forecast period (2021-2028).
Key Trends and Analysis of the Global Duck Medicine and Vaccines Market:
Key trends in the market include increased research and development activities by the key players and scientists, which are expected to drive the market growth over the forecast period. For instance, in April 2018, researchers at the Pirbright Institute, a research institute in Surrey, England, developed a single vaccine for avian flu and duck enteritis. The researchers used a method of CRISPR/Cas9 gene editing that allows higher rates of gene editing, making the process more efficient. The resulting vaccine can protect ducks against both duck enteritis virus (DEV) and avian influenza.
Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4956
Key Market Takeaways:
The global duck medicine and vaccines market is expected to exhibit a CAGR of 7.7% during the forecast period due to the increasing research and development program by the government, which is expected to drive the market growth over the forecast period. For instance, in 2018, the NER Duck program was initiated by the Indian government that focuses on breeding of duck by converging conventional and molecular techniques, disease mapping and development of diagnostics for economically important diseases, developing molecular platform for epidemiology, development of vaccine against duck plague virus, and others.
Among the type, the vaccines segment is estimated to hold a dominant position over the forecast period, owing to the routine immunizations carried out for the prevention of diseases in ducks. Diseases such as duck plague, duck viral hepatitis, and others, have no treatment available and therefore vaccination is the only way to prevent such diseases. For instance, duck viral hepatitis mainly affects ducklings of 2 to 3 weeks of age and there is no treatment option available and so they can be immunized by an attenuated strain of virus before the commencement of egg production.
Among application, the farm segment is estimated to account for the largest market share in the global duck medicine and vaccines market over the forecast period. For instance, according to the data provided by Sentient Media, a nonprofit news organization, in January 2022, ducks can serve as an important source for providing eggs or meat in the farms.
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4956
Competitive Landscape:
Key players operating in the global duck medicine and vaccines market include Boehringer Ingelheim International GmbH., Ceva, YEBIO BIOENGINEERING CO., LTD., NAVETCO, Shangqiu Meilan Biological Engineering Co.,Ltd., Merck & Co., Inc., EGAVET, Bioveta, a.s., Jilin Zhengye Biological Products company limited, and Harbin Pharmaceutical Group Bio-vaccine Co. Ltd.
Market Segmentation:
- Global Duck Medicine and Vaccines Market, By Type:
-
- Medicine
- Vaccines
- Global Duck Medicine and Vaccines Market, By Application:
-
- Farm
- Application
- Global Duck Medicine and Vaccines Market, By Region:
- North America
- By Country
- U.S.
- Canada
- By Country
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Country
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Country
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- By Country
- Africa
- By Country
- South Africa
- Central Africa
- North Africa
- By Country
- North America
Related Market Intelligence Reports:
Animal Vaccines Market, by Product Type (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines), by Application (Companion Animal, Livestock Animal, Poultry, and Aquaculture), by Distribution Channel (Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
Vaccines Market, by Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Toxoid Therapy, and Recombinant Therapy), by Type (Monovalent Vaccines and Multivalent Vaccines), by Indication (Typhoid, Hepatitis, Pneumococcal, DTP, Malaria, Influenza, Human Papilloma Virus, Meningococcal, Polio, Rotavirus, MMR, Varicella, Herpes Zoster, and Others), by Route of Administration (Parenteral Administration and Oral Administration), by Age Group (Pediatric and Adult), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
